Ovarian tissue cryopreservation (OTC) for fertility preservation in young cancer survivors- Comparison of slow freezing and vitrification techniques

Indian Council of Medical Research0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: U072- COVID 19 virus not identified

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Health Condition 1: U072- COVID 19 virus not identified
Sponsor: Indian Council of Medical Research
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Investigators

Sponsor

Indian Council of Medical Research

Eligibility Criteria

Inclusion Criteria

•i)Patients with good prognosis for survival after chemo/radiotherapy requiring OTC
•a.Pubertal ages with malignancy
•b.Adults in reproductive years for immediate chemo/radiotherapy with little time for oocyte/embryo freezing as this requires 2\-3 weeks of ovarian stimulation and oocyte recovery and embryo culture
•ii)Willing to participate in the study

Exclusion Criteria

•i)Patients with poor prognosis for survival
•ii)Medical complications not permitting laparoscopy/anaesthesia to harvest ovarian tissue
•iii)Not willing to participate in study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting

Not Applicable

Ovarian tissue cryopreservation for fertility-preservation of Children and young adults with cancerCancer patient

JPRN-UMIN000021746Graduate school of medicine, Kyoto University Department of obstetrics and gynecology30

Recruiting

Not Applicable

Ovarian tissue cryopreservation for fertility preservatioPremature ovarian insufficiency

JPRN-UMIN000043460Sapporo Medical University33

Recruiting

Not Applicable

Ovarian tissue cryopreservation as fertility preservation after childhood cancer treatment followed by long-term observation after storage.Cancer in children and AYAChildhood cancer, CAYA

JPRN-jRCT1050220005Fujisaki Hiroyuki100

Recruiting

Not Applicable

Oocyte cryopreservation for fertility-preservation of young woman in cancer and immune disease.Cancer patient including hematological malignancy, autoimmune disease such as SLE, premature ovarian failure

JPRN-UMIN000015212Graduate school of medicine, Kyoto University Department of obstetrics and gynecology100

Completed

Not Applicable

Oocyte cryopreservation for fertility preservation in women with cancer and autoimmune disease.

JPRN-UMIN000027163Kyoto Prefectural University of Medicine10